Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...

Quadrise appoints marine expert Tony Foster as Non-Executive Director

Quadrise Plc (LON: QED) welcomes Tony Foster as Non-Executive Director, enhancing their maritime and decarbonisation expertise from February 2025...

Time Finance reports record lending book, fourteen consecutive quarters of growth

Time Finance plc's interim results show impressive growth, with a 16% revenue increase and a 44% rise in profit. Explore their strategic updates...

Diversified Energy expands asset base with Maverick Natural Resources acquisition

Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...

Tekmar Group awarded £5 million offshore wind farm contract

Tekmar Group secures a £5M contract for a UK offshore wind project, highlighting its leading cable protection system and engineering expertise...

hVIVO selected to conduct large-scale phase 3 Whooping Cough trial

hVIVO partners with ILiAD Biotechnologies for the first-ever Phase 3 human challenge trial of BPZE1, a next-gen Bordetella pertussis vaccine...

Ashtead Group initiates $1.5 billion share buyback programme

Ashtead Group plc announces a $1.5bn share buyback arrangement with Barclays Bank, aiming to reduce share capital within 18 months...

British American Tobacco forecasts strong H2 growth and new categories innovation

British American Tobacco Plc is set to deliver its FY24 guidance, boosted by New Categories innovation and strategic investments, amidst strong cash flow...

Games Workshop Group grants exclusive rights to Amazon for Warhammer 40,000 universe films and series

Games Workshop strikes deal with Amazon to adapt Warhammer 40,000 into films and series, granting exclusive rights and exploring merchandising opportunities...

Centrica Plc holding teach-in for institutional investors and analysts on its MAP businesses

Centrica plc (LON:CNA) reports strategic progress and stable 2024 earnings, as it hosts an investor teach-in on Centrica Energy and MAP businesses today...

CMC Markets Plc CFO Albert Soleiman to step down

CMC Markets plc announces the immediate departure of CFO Albert Soleiman, with support for a smooth transition as he steps down as director...

Bluefield Solar Income Fund completes £300 million refinancing

Bluefield Solar Income Fund Limited announces successful refinancing of a 359MW solar PV portfolio with GLIL Infrastructure, enhancing growth and asset management...

Supermarket Income REIT Plc updates on key portfolio initiatives

Supermarket Income REIT (LON:SUPR) advances strategic portfolio initiatives, including key sales and lease renewals, enhancing shareholder value and earnings...

B&M European Value Retail Group Chief Executive Alex Russo to retire from Board

B&M European Value Retail's CEO Alex Russo to retire in April 2025 as the company updates its FY25 profit guidance to reflect market conditions...

City of London Investment Trust NAV outperforms benchmarks

City of London Investment Trust PLC (LON:CTY) reports a 2.8% net asset value return for the half-year ending December 2024, outperforming its benchmarks...

Diversified Energy Company publishes approved Prospectus

Diversified Energy Company Plc announces FCA approval of a prospectus and plans to list shares on the LSE and NYSE, alongside a significant acquisition update...

AIM All Share Index

Trending Articles

Search

Search

Currency

[mailpoet_form id="59"]